Pfizer

{
  "main_header": {
    "sid": 970356,
    "name": "Pfizer",
    "stock_name": "Pfizer",
    "full_name": "Pfizer Ltd.",
    "name_url": "stocks-analysis/pfizer",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,708.15",
    "chg": -56,
    "chgp": "-1.18%",
    "dir": -1,
    "prev_price": "4,764.15",
    "mcapval": "21,631.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500680,
    "symbol": "PFIZER",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE182A01018",
    "curr_date": "Apr 30",
    "curr_time": "",
    "bse_nse_vol": "8.0 k",
    "exc_status": "Active",
    "traded_date": "Apr 30, 2026",
    "traded_date_str": "2026 04 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pfizer-970356-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Pfizer Ltd. is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-3969990",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PfizerLtd_mojoScore_3969990.png",
        "date": "2026-04-30 10:10:38",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-amid-mixed-market-signals-3955115",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PfizerLtd_technicaldot_3955115.png",
        "date": "2026-04-21 08:05:28",
        "description": "Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest a cautious outlook for investors amid mixed signals."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-3952878",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PfizerLtd_mojoScore_3952878.png",
        "date": "2026-04-19 10:10:37",
        "description": "Pfizer Ltd. is currently rated Sell by MarketsMOJO, a rating that was last updated on 29 December 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the stock’s current position as of 19 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-3937348",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PfizerLtd_mojoScore_3937348.png",
        "date": "2026-04-08 10:10:35",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-bearish-amid-market-volatility-3923441",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_technicaldot_3923441.png",
        "date": "2026-03-30 08:02:33",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish stance. This transition is underscored by deteriorating technical indicators including MACD, Bollinger Bands, and moving averages, signalling increased selling pressure despite some bullish volume trends. Investors should carefully analyse these developments as the stock navigates a challenging market environment."
      },
      {
        "title": "Pfizer Ltd. is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pfizer-ltd-is-rated-sell-by-marketsmojo-3921500",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_mojoScore_3921500.png",
        "date": "2026-03-28 10:10:15",
        "description": "Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3918518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_technicaldot_3918518.png",
        "date": "2026-03-27 08:02:37",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators suggest a cautious outlook for investors navigating this evolving landscape."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-to-bearish-amid-market-pressure-3909214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_technicaldot_3909214.png",
        "date": "2026-03-24 08:04:11",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating technical parameters, suggests increased selling pressure and a cautious outlook for investors."
      },
      {
        "title": "Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pfizer-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3898018",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/PfizerLtd_technicaldot_3898018.png",
        "date": "2026-03-18 08:02:12",
        "description": "Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters suggest a nuanced outlook for investors navigating this evolving landscape."
      }
    ],
    "total": 358,
    "sid": "970356",
    "stock_news_url": "https://www.marketsmojo.com/news/pfizer-970356"
  },
  "announcements": [
    {
      "caption": "Intimation Pursuant To Regulation 30 Of SEBI LODR Regulations 2015",
      "datetime": "24-Apr-2026",
      "details": "Pursuant to Regulation 30 of SEBI LODR Regulations 2015 we hereby inform the receipt of an Assessment Order and tax demand issued by Income Tax Department - Assessment Unit",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Apr-2026",
      "details": "Newspaper Advertisement - Special Window for Re - lodgement of transfer and Dematerialization of Physical Securities.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Pfizer Ltd. has declared <strong>350%</strong> dividend, ex-date: 09 Jul 25",
          "dt": "2025-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pfizer Ltd. is Rated Sell

2026-04-30 10:10:38

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Market Signals

2026-04-21 08:05:28

Pfizer Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. This transition is underscored by a complex interplay of technical indicators, including MACD, RSI, moving averages, and Bollinger Bands, which collectively suggest a cautious outlook for investors amid mixed signals.

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-04-19 10:10:37

Pfizer Ltd. is currently rated Sell by MarketsMOJO, a rating that was last updated on 29 December 2025. While this rating change occurred several months ago, the analysis and financial metrics presented here reflect the stock’s current position as of 19 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-04-08 10:10:35

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 April 2026, providing investors with an up-to-date view of the company's performance and outlook.

Read full news article

Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Volatility

2026-03-30 08:02:33

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish stance. This transition is underscored by deteriorating technical indicators including MACD, Bollinger Bands, and moving averages, signalling increased selling pressure despite some bullish volume trends. Investors should carefully analyse these developments as the stock navigates a challenging market environment.

Read full news article

Pfizer Ltd. is Rated Sell by MarketsMOJO

2026-03-28 10:10:15

Pfizer Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-27 08:02:37

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators suggest a cautious outlook for investors navigating this evolving landscape.

Read full news article

Pfizer Ltd. Technical Momentum Shifts to Bearish Amid Market Pressure

2026-03-24 08:04:11

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating technical parameters, suggests increased selling pressure and a cautious outlook for investors.

Read full news article

Pfizer Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-18 08:02:12

Pfizer Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters suggest a nuanced outlook for investors navigating this evolving landscape.

Read full news article

View All News